SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of NeueHealth, Inc. (NEUE)
- 82
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - December 27, 2024) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE: NEUE) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to an affiliate of New Enterprise Associates ("NEA"). Under the terms of the agreement, NEA will purchase the Company for $7.33 per share in an all-cash transaction valued at approximately $1.3 billion on an enterprise basis.
The investigation concerns whether the NeueHealth Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal offers fair value to the Company's shareholders.
If you own shares of NeueHealth stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at [email protected], visit https://www.brodskysmith.com/cases/neuehealth-inc-nyse-neue/, or call toll free 855-576-4847.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235339
Newsfile Corp. est une société de service sur les communiqués de presse destinée pour des entreprises de toutes tailles. Avec une distribution de plus de 6 000 bases de données médiatiques et financières, Newsfile livre des communiqués de presse à un public mondial.
- Amex annonce le dépôt du rapport technique d'évaluation économique préliminaire (EEP) pour le projet aurifère Perron
- Kerecis, la société spécialisée dans l'utilisation de la peau de poisson à des fins médicales, élargit sa gamme de produits combinés poisson-peau à base de silicone pour les plaies chirurgicales et traumatiques avec le silicone SurgiClose®
- Le TEVIMBRA est approuvé aux États-Unis pour le traitement de première intention des cancers gastrique et de la jonction gastro-œsophagienne en association avec une chimiothérapie
- Suspension du Contrat de Liquidité
- ATARI: HALF-YEAR 2024/2025 RESULTS
- EQUASENS : acquisition stratégique de Calimed, expert en logiciel SaaS pour les médecins libéraux et les chirurgiens